Intrarenal Complement System Transcripts in Chronic Antibody-Mediated Rejection and Recurrent IgA Nephropathy in

Marek Cernoch1, Petra Hruba1, Marek Kollar2

  • 1Transplant Laboratory, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czechia.

Frontiers in Immunology
|October 26, 2018
PubMed

Insights

Complement system transcripts are upregulated in deteriorating kidney allografts, impacting chronic antibody-mediated rejection and IgA nephropathy recurrence. Intrarenal complement gene expression correlates with kidney function and disease progression.

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation Science

Background:

  • Complement system activation is implicated in kidney transplant pathologies like chronic antibody-mediated rejection (cAMR) and IgA nephropathy recurrence (ReIgAN).
  • Distinct mechanisms of complement involvement in cAMR and ReIgAN require further elucidation.

Purpose of the Study:

  • To investigate the role of complement cascade and regulatory gene transcripts in kidney allografts with cAMR and ReIgAN.
  • To compare complement gene expression profiles between cAMR, ReIgAN, stable kidney grafts, and native IgAN.

Main Methods:

  • Retrospective analysis of 150 kidney transplant recipients diagnosed with cAMR or ReIgAN.
  • RT-qPCR analysis of 11 complement-related genes in kidney biopsy samples.
  • Immunohistological staining for CD46 and C5 proteins.
  • Comparison with 14 stable grafts and 11 native IgAN patients.

Main Results:

  • No significant difference in kidney graft survival between cAMR and ReIgAN groups.
  • cAMR showed higher intragraft transcripts for C3, CD59, and C1-INH compared to ReIgAN.
  • cAMR grafts had increased C3, CD55, CD59, CFH, CFI, and C1-INH transcripts versus stable grafts.
  • ReIgAN demonstrated increased CD46, CD55, CD59, and CFI transcripts compared to native IgAN.
  • Lower intrarenal CD55 expression predicted rapid cAMR progression.
  • Several complement transcripts (C3, CD55, CFH, CFI, C1-INH) positively correlated with estimated glomerular filtration rate (eGFR).

Conclusions:

  • Intrarenal complement system transcripts are upregulated in progressively deteriorating kidney allografts.
  • Complement gene expression patterns differ between cAMR, ReIgAN, and stable grafts.
  • Intrarenal complement activation and regulation play a significant role in kidney allograft dysfunction.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
453
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
728
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
411
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
653
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
399
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.7K